These findings are supported by the fact that intermediate proinsulin products like des-31,32 or des-62,64 proinsulin are elevated in IR and diabetes patients [12,13], showing that the processing of proinsulin to insulin in β cells is impaired. Here, INS is linked to diabetes mellitus.